IABP as a Bridge to Transplantation: Can we Identify Who May Benefit From a LVAD?

被引：0
|
作者：
Guha, A. [1 ]
Ali, A. [1 ]
Nguyen, D. [1 ]
Bruckner, B. [1 ]
Trachtenberg, B. [1 ]
Graviss, E. A. [1 ]
Bhimaraj, A. [1 ]
Park, M. H. [1 ]
Hussain, I. [1 ]
Suarez, E. E. [1 ]
Torre-Amione, G. [1 ]
Estep, J. [1 ]
机构：
[1] Houston Methodist Hosp, Methodist DeBakey Heart Ctr, Houston, TX USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.667
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
664
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [31] Can we identify patients who may have an optimal response to balloon angioplasty alone? Insights from the DESTINI trial.
    Moussa, I
    Colombo, A
    Di Francesco, L
    Lawrence, E
    Di Mario, C
    Moses, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (6A): : 115P - 116P
  • [32] Ischemic mitral regurgitation: can we identify who is at risk?
    Tischler, Marc D.
    CORONARY ARTERY DISEASE, 2015, 26 (08) : 637 - 638
  • [33] Can stress echocardiography identify patients who will benefit from percutaneous mitral valve repair?
    Velu, J. F.
    Baan, J., Jr.
    de Bruin-Bon, H. A. C. M.
    van Mourik, M. S.
    Nassif, M.
    Koch, K. T.
    Vis, M. M.
    van den Brink, R. B.
    Boekholdt, S. M.
    Piek, J. J.
    Bouma, B. J.
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2019, 35 (04): : 645 - 651
  • [34] Can stress echocardiography identify patients who will benefit from percutaneous mitral valve repair?
    J. F. Velu
    J. Baan Jr
    H. A. C. M. de Bruin-Bon
    M. S. van Mourik
    M. Nassif
    K. T. Koch
    M. M. Vis
    R. B. van den Brink
    S. M. Boekholdt
    J. J. Piek
    B. J. Bouma
    The International Journal of Cardiovascular Imaging, 2019, 35 : 645 - 651
  • [35] Optical pre-screening in breast screening programs: Can we identify women who benefit most from limited mammography resources?
    Walter, Jane
    Loshchenov, Maxim
    Zhilkin, Vladimir
    Peake, Rachel
    Stone, Jennifer
    Lilge, Lothar
    INTERNATIONAL CONFERENCE ON BIOPHOTONICS V, 2017, 10340
  • [36] Characterizing Robust Hemodynamic Response to IABP Therapy in Chronic Heart Failure Patients with Cardiogenic Shock: Can We Identify IABP Super: Responders?
    Nair, Abhinav
    Fried, Justin
    Masoumi, Amir
    Topkara, Veli
    Clerkin, Kevin
    Finn, Matthew
    Takeda, Koji
    Kirtane, Ajay
    Yuzefpolskaya, Melana
    Takayama, Hiroo
    Naka, Yoshifumi
    Colombo, Paolo
    Garan, Arthur
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (08) : S30 - S30
  • [37] Incidence and predictors of pacemaker dysfunction with unipolar ventricular lead configuration.: Can we identify patients who benefit from bipolar electrodes?
    Wiegand, UKH
    Bode, F
    Bonnemeier, H
    Tölg, R
    Peters, W
    Katus, HA
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (09): : 1383 - 1388
  • [38] Use of clinical pathways to identify patients with cancer who may benefit from serious illness conversations
    Cotner, Cody E.
    Tramontano, Angela
    Jackman, David Michael
    Tulsky, James A.
    Jacobson, Joseph
    Rice, Matthew
    Post, Alex
    Finn, Brian
    Mwesigwa, Sishemo
    Lindvall, Charlotta
    Wright, Alexi A.
    Manz, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?
    Mackinnon, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) : 12 - 17
  • [40] Readily available clinical features can help identify patients with intermediate-high risk pulmonary emboli who may benefit from thrombolysis
    Abuhalaweh, N.
    Rupani, H.
    Brown, M.
    THORAX, 2023, 78 (SUPPL_4) : A198 - A198
12345